JPMorgan Chase & Co. Issues Pessimistic Forecast for Amrize (NYSE:AMRZ) Stock Price

Amrize (NYSE:AMRZ – Get Free Report) had its target price reduced by equities research analysts at JPMorgan Chase & Co. from $48.00 to $46.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 17.77% from the company’s previous close.

Several other equities research analysts also recently issued reports on AMRZ. UBS Group raised their target price on shares of Amrize from $42.00 to $46.00 and gave the company a “hold” rating in a research note on Monday, November 16th. Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 19th. Jefferies Financial Group downgraded Amrize from a “hold” rating to an “underperform” rating and lowered their price target for the stock from $42.80 to $35.20 in a research report on Monday. Wells Fargo & Company dropped their price objective on Amrize from $40.00 to $39.00 and set an “equal weight” rating on the stock in a research note on Friday, October 30th. Finally, Oppenheimer dropped their price objective on Amrize from $55.00 to $52.00 and set an “outperform” rating on the stock in a research note on Monday, November 2nd. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $47.07.

Check Out Our Latest Research Report on Amrize

Amrize Price Performance

Shares of AMRZ opened at $39.06 on Thursday. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $39.17 and its 200 day simple moving average is $49.65. Amrize has a 1-year low of $35.78 and a 1-year high of $65.94. The company has a market cap of $21.60 billion, a price-to-earnings ratio of 17.67, a PEG ratio of 1.59 and a beta of 0.04.

Amrize (NYSE:AMRZ – Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting analysts’ consensus estimates of $1.05. The company had revenue of $3.77 billion during the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The business’s revenue was up 2.6% on a year-over-year basis. During the same period last year, the business earned $0.98 EPS. On average, research analysts forecast that Amrize will post 2.30 earnings per share for the current fiscal year.

Insider Buying and Selling at Amrize

In related news, CEO Jan Jenisch acquired 26,000 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The shares were bought at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the transaction, the chief executive officer directly owned 1,767,000 shares of the company’s stock, valued at $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jacques Sanche bought 4,150 shares of the business’s stock in a transaction dated Wednesday, August 26th. The shares were bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director owned 9,766 shares in the company, valued at $439,665.32. The trade was a 73.90% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 34,155 shares of company stock worth $1,461,276. Corporate insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Grove Bank & Trust boosted its holdings in Amrize by 2.1% in the 3rd quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock valued at $653,000 after purchasing an additional 353 shares during the period. Rothschild Investment LLC raised its position in shares of Amrize by 5.3% in the third quarter. Rothschild Investment LLC now owns 7,876 shares of the company’s stock valued at $294,000 after buying an additional 395 shares in the last quarter. Norman Fields Gottscho Capital Management LLC raised its position in shares of Amrize by 4.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after buying an additional 475 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Amrize by 3.9% in the third quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock valued at $542,000 after buying an additional 543 shares during the period. Finally, Choreo LLC boosted its stake in shares of Amrize by 4.2% in the third quarter. Choreo LLC now owns 17,713 shares of the company’s stock valued at $662,000 after buying an additional 706 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.